Janus Henderson Investors, an investment management company, released its “Janus Henderson Venture Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Welcome to Skura Weekly! 🚗🔥 Your ultimate destination for cars, speed, and all things automotive! From car reviews and test drives to modifications and industry news, this channel brings you ...

Google’s Veo 3 AI video generating software is now available to try in Vertex AI in public preview - here’s what you need to know.

Vertex Pharma's stem cell therapy may have potential to cure type-1 diabetes, shows clinical trial During a clinical trial, around 83% (10 out of 12) of patients who received a full dose of ...

Vertex Pharmaceuticals: 2025 TIME100 Most Influential CompaniesBoston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR ...

Sales of the ground-breaking cystic fibrosis (CF) drug Kaftrio was the main driver behind revenues of a Dublin unit of Vertex Pharmaceuticals surging to $2.63bn (€2.26bn) last year.

We propose a scalable graph processing hardware accelerator called NOVA that is based on a novel vertex management architecture that decouples the execution of reduction and propagation operations in ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex Pharmaceuticals announced the simultaneous presentation and publication of ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...

Kazam, an electric mobility infrastructure startup, secured $6.2 million in funding led by the International Finance Corporation (IFC) to expand its EV charging and battery swapping solutions. The ...